Celldex Therapeutics (CLDX) EBITDA Margin Growth (3y) (2013 - 2026)
Celldex Therapeutics (CLDX) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn | -55.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.95 Mn |
| Dec 31, 2025 | -7.03 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 433,890.00 |
| Dec 31, 2024 | 132,157.00 |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -146,796.00 |
| Mar 31, 2024 | -2.36 Mn |
| Dec 31, 2023 | -49,837.00 |
| Sep 30, 2023 | -57,145.00 |
| Jun 30, 2023 | -757,425.00 |
| Mar 31, 2023 | -264,308.00 |
| Dec 31, 2022 | -26,439.00 |
| Sep 30, 2022 | -463,568.00 |
| Jun 30, 2022 | -2.06 Mn |
| Mar 31, 2022 | -1.21 Mn |
| Dec 31, 2021 | -540,258.00 |
| Sep 30, 2021 | -1.28 Mn |
| Jun 30, 2021 | 22,447.00 |
| Mar 31, 2021 | 51,286.00 |